Categories
Latest News
- Toft Group Executive Search Places Ellen Lubman on Board of Advisors at TMRW Life Sciences, Inc. in New York, NY09/12/2019 - 11:06 AM
- Toft Group Executive Search Places Chris Cournoyer on Board of Directors for CareDx, Inc. in Brisbane, CA08/27/2019 - 10:12 AM
- Toft Group Executive Search Places Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY08/19/2019 - 10:00 AM
Toft Group Executive Search Places Ellen Lubman on Board of Advisors at TMRW Life Sciences, Inc. in New York, NY
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Ellen Lubman on Board of Advisors at TMRW Life Scienc
As Chief Business Officer of Impel Neuropharma, Ms. Lubman leads corporate development activities and strategy for the private neuroscience therapeutics company.
Prior to joining Impel, she served as the Vice President of External Science & Innovation at Allergan, where she was responsible for strategic expansion of the company’s pipeline in a variety of disease areas, including women’s health.
“We are thrilled to have Ellen join our Advisory Board,” said Alan Murray, TMRW’s Founder and Co-CEO. “Her deep interest in and understanding of the assisted reproductive technology landscape and her experience as a senior leader at life sciences companies at every stage of development make her an ideal advisor for TMRW, especially regarding strategic partnering and financing initiatives.”
Ms. Lubman has 20 years of biopharmaceutical corporate development and Wall Street industry experience, including roles at Kadmon Pharmaceuticals, Bristol-Myers Squibb, Celtic Pharma Management, L.P. and Robertson Stephens. She is a member of the Board of Directors of Dauntless Pharmaceuticals and GeneCentric Therapeutics.
About TMRW
In coming decades, a rapidly scaling fertility industry and increased access to IVF therapies will be responsible for nearly 300 million global births — almost all of which will rely upon frozen fertility cells. To meet this rapidly growing demand, TMRW has created the first fully Robotic Process Automation (RPA) platform designed specifically for IVF. Already experiencing rapid market adoption, TMRW is poised to become the global standard for cryo-preservation and fertility cell management. IVF clinicians have embraced TMRW’s RPA platform because it replaces an outdated analog IVF cryo-management function with proven risk-mitigating Robotic Process Automation technology.
TMRW provides the world’s first complete RFID cryo-temperature compatible digital chain of custody for all fertility cells—including embryos and gametes. TMRW software is constantly vigilant and automates 17,000 daily environmental “health checks” that ensure the safety and security of the world’s most precious cells.
TMRW’s co-founders, Joshua Abram, Alan Murray and Dr. Jeff Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
Toft Group Executive Search Places Chris Cournoyer on Board of Directors for CareDx, Inc. in Brisbane, CA
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Chris Cournoyer on the Board of Directors for CareDx, Inc. in Brisbane, CA.
“Chris brings deep experience in technology and her recent experiences with EHR and CDS solutions will be invaluable,” comments Peter Maag, CareDx Chief Executive Officer, “as we build out our offerings in Digital Transplant Solutions.”
Cournoyer was previously the Chairperson and Chief Executive Officer for N-of-One. N-of-One is a leader in precision medicine delivering clinical and molecular decision support for targeted therapies decisions based on a cancer patient’s molecular profile. Prior, she was the Vice President of Clinical Analytics at Optum, through the acquisition of Picis where she was the President and COO. At Optum and Picis, Cournoyer was responsible for clinical EHR solutions and clinical decision support (CDS) solutions. Cournoyer has also held roles at Harte Hanks, Lotus, and IBM. At Lotus she was the Chief Information Officer. At IBM she was Vice President of Global Business Transformation responsible for driving the digital strategy for global software fulfillment for the $8B software business.
Ron Giannotti, President and CEO of Toft Group said: “CareDx is an exceptionally innovative company with an incredibly strong leadership team. Chris will add significant value to the organization, and will be a strong contributor to the future growth of the company.”
She has provided technology expertise and guidance on the digital strategy for three public boards including Stride Rite, GTECH, and BJ’s Wholesale group, and has been a director for Emerson Hospital. Cournoyer holds a B.S in Business Administration, University of Massachusetts, an MA in Economics, Northeastern University and has attended MIT ‘s Executive Education Program.
“I look forward to bringing my experiences to impact care for transplant patients. CareDx is well positioned to be the data leader in transplant, and I am excited to join the board working closely with the management team to positively impact patients’ lives,” said Chris Cournoyer.
About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers products, testing services and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.
Toft Group Executive Search Places Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY
/in Press Releases /by ToftgroupToft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Lori Batta as Chief Commercial Officer at TMRW Life Sciences, Inc. in New York, NY.
Lori Batta was previously Chief Commercial Officer at Celmatix, Inc., a next generation women’s health company. Prior to Celmatix, Batta served as Senior Vice President, Business Development and Strategic Alliances at Good Start Genetics (GSG), where she led the company’s global business development strategy. During her time at GSG, Batta was responsible for the launch of the first next-generation sequencing carrier screen and drove more than $100M in revenue in its first three years in the market.
Batta also served as Senior Director, Commercial with Javelin Pharmaceutical, where she directed regulatory and commercialization strategy for the Javelin Pain Franchise for three late-stage specialty pain products. Before Javelin, she served as Vice President of Sales and Marketing for MDR Specialty Pharma, and Vice President of Sales, Reproductive Health for EMD Serono.
Batta holds a B.A. in Biology from College of St. Elizabeth, Convent Station, NJ.
About TMRW
In coming decades, a rapidly scaling fertility industry and increased access to IVF therapies will be responsible for nearly 300 million global births—almost all of which will rely upon frozen fertility cells. To meet this rapidly growing demand, TMRW has created the first fully Robotic Process Automation (RPA) platform designed specifically for IVF. Already experiencing rapid market enthusiasm, TMRW is poised to become the global standard for cryo-preservation and fertility cell management. IVF clinicians have embraced the concept of TMRW’s risk-mitigating RPA platform as a replacement for current less sophisticated analog IVF cryo-management systems. TMRW provides the world’s first complete RFID cryo-temperature compatible digital chain of custody for all fertility cells—including embryos and gametes. TMRW software is constantly vigilant and automates 17,000 daily environmental “health checks” that ensure the safety and security of the world’s most precious cells.
TMRW’s co-founders, Joshua Abram, Alan Murray and Dr. Jeff Port, are serial tech and life sciences entrepreneurs. Their immediate prior ventures sold for a combined sum of more than $1 billion. www.tmrw.org
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego and Boston.